Known for developing Erbitux, a monoclonal antibody that inhibits the stimu
Known for developing Erbitux, a monoclonal antibody that inhibits the stimulation of the epidermal growth factor receptor, the company also develops inhibitors for angiogenesis, important for treating cancer. Samuel Waksal, its former chief executive was arrested and charged with securities fraud, tipping off family members to sell off their shares in advance of an unfavorable FDA ruling. For 10 points—identify this biopharmaceutical company.
Known for developing Erbitux, a monoclonal antibody that inhibits the stimulation of the epidermal growth factor receptor, the company also develops inhibitors for angiogenesis, important for treating cancer.
{ImClone} Systems